FRESEN.MED.CARE KGAA O.N.
FRESEN.MED.CARE KGAA O.N./ DE0005785802 /
FME
21/05/2024 17:35:10
|
Chg.
-0.890
|
Volume |
Bid17:40:12 |
Demandez à17:35:10 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
39.600EUR
|
-2.20%
|
447,946 Chiffrre d'affaires: 17.74 Mio. |
-Bid taille: - |
-Ask la taille: - |
11.58 Mrd.EUR |
3.01% |
23.22 |
Description de l'entreprise
Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 2.8 M patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
Conseil d'administration & Conseil de surveillance
PDG |
Helen Giza |
Conseil d'administration |
Martin Fischer, Dr. Katarzyna Mazur-Hofsäß, Frank Maddux, MD, Craig Cordola |
Conseil de surveillance |
Michael Sen, Stefanie Balling, Sara Hennicken, Shervin J. Korangy, Dr. Marcus Kuhnert, Gregory Sorensen, M.D., Pascale Witz, Ralf Erkens, Beate Haßdenteufel, Regina Karsch, Frank Michael Prescher, Dr. Manuela Stauss-Grabo |
Données de l'entreprise
Nom: |
Fresenius Medical Care AG & Co. KGaA |
Adresse: |
Else-Kröner-Straße 1,D-61352 Bad Homburg |
Téléphone: |
+49-6172-609-0 |
Fax: |
+49-6172-609-2301 |
Courriel: |
-
|
Internet: |
www.fmc-ag.de |
Industrie: |
Healthcare |
Secteur: |
Medical Products |
Sous-secteur: |
Advanced Medical Devices |
Fin de l'exercice financier: |
31/12 |
Flotte libre: |
44.95% |
IPO date: |
02/10/1996 |
Relations avec les investisseurs
Nom: |
Dr. Dominic Heger |
Téléphone IR: |
+49 (0) 6172 609-2525 |
IR-Fax: |
+49 (0) 6172 609-2301 |
E-mail IR: |
ir@fmc-ag.com
|
Calendrier de l'entreprise
CW 21 | 22/05/2024
Dividend Payment
|
CW 31 | 30/07/2024
Interim Report 2nd Quarter/6 Months
|
CW 45 | 05/11/2024
Interim Report 3rd Quarter/9 Months
|